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ABSTRACT
The Klebsiella pneumoniae species complex in-
cludes important opportunistic pathogens which
have become public health priorities linked to ma-
jor hospital outbreaks and the recent emergence
of multidrug-resistant hypervirulent strains. Bacte-
rial virulence and the spread of multidrug resistance
have previously been linked to toxin–antitoxin (TA)
systems. TA systems encode a toxin that disrupts
essential cellular processes, and a cognate antitoxin
which counteracts this activity. Whilst associated
with the maintenance of plasmids, they also act in
bacterial immunity and antibiotic tolerance. However,
the evolutionary dynamics and distribution of TA sys-
tems in clinical pathogens are not well understood.
Here, we present a comprehensive survey and de-
scription of the diversity of TA systems in 259 clini-
cally relevant genomes of K. pneumoniae. We show
that TA systems are highly prevalent with a median
of 20 loci per strain. Importantly, these toxins dif-
fer substantially in their distribution patterns and
in their range of cognate antitoxins. Classification
along these properties suggests different roles of
TA systems and highlights the association and co-
evolution of toxins and antitoxins.
INTRODUCTION
The Klebsiella pneumoniae species complex, which includes
K. pneumoniae sensu stricto, Klebsiella quasipneumoniae
and Klebsiella variicola, is a major threat to public health.
Members of this species complex are leading causes of op-
portunistic infections in hospitalised or immunocompro-
mised patients (1,2) and increasingly linked to major hos-
pital outbreaks by highly multidrug resistant isolates (3,4).
Of particular concern is the recent emergence of conver-
gent multidrug-resistant and hypervirulent strains; these
two phenotypes, both carried on mobile elements, were so
far considered mutually exclusive. These new strains cause
serious community-acquired infections in otherwise healthy
individuals with few treatment options given their extensive
drug resistance profiles (5–9).
The spread of genetic elements that act as the vectors
of antibiotic resistance and virulence determinants have re-
peatedly been linked to toxin–antitoxin (TA) systems (10–
12). TA systems were first discovered as loci that enforce
the maintenance of plasmids via post-segregational killing
(13). They are comprised of bicistronic operons encoding a
toxin which inhibits cellular processes, such as translation
or DNA replication and an antitoxin which counteracts the
toxins’ harmful activity. Typically, the antitoxin is less sta-
ble than the toxin, and thus following binary fission the an-
titoxin degrades more rapidly leading to any plasmid-free
daughter cell being killed by the more stable toxin.
Since their first description, it has become clear that TA
systems are ubiquitous across a broad range of prokary-
otic plasmids and chromosomes (14–19). Furthermore, in
addition to post-segregational killing they have roles in
other important cellular processes such as the formation
of antibiotic-induced persistence (20), defence against bac-
teriophages, biofilm formation (21–23) and through tran-
scriptional read-through can influence the expression of ad-
joining genes (24).
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There are six different types of TA systems, defined by the
antitoxin and its mode of inhibition of the toxin (16,22,25).
The most well studied TA systems, and the focus of this
study are the type II TA systems: both toxin and antitoxin
are proteins with the antitoxin inhibiting the toxin’s activity
through direct interaction. Similarly, type IV TA systems,
also included in this study, are comprised of protein toxin
and antitoxin however, their antitoxin inhibits the toxin’s
activity by interacting with the toxin’s target.
Whilst TA systems have been well studied in a limited
number of laboratory and clinical isolates ofEscherichia coli
(20,26–28) and Salmonella enterica sv. Typhimurium (29)
little is known about their distribution or their full diver-
sity in the K. pneumoniae species complex (19,30). Further-
more, there have been no studies in any bacterium that have
considered investigating these systems using large clinically
relevant collections.
Here we present the detection and phenotypic testing of
known, variant and novel TA combinations as well as a sys-
tematic analysis of the diversity of TA systems in a collec-
tion of 259 K. pneumoniae species complex strains, includ-
ing K. pneumoniae sensu stricto, K. quasipneumoniae and
K. variicola (31). Whilst TA systems have been known to
be common in K. pneumoniae plasmids and chromosomes
based on studies with a small number of isolates (15,19),we
show that they differ substantially in their distribution pat-
terns and in the nature of the pairings between toxins and
cognate antitoxin. Moreover, some TA systems are associ-
ated with the presence of clinically important genes, others
are ubiquitous or specific to a species within this complex,
alluding to different evolutionary dynamics. This compre-
hensive analysis highlights the different evolutionary pro-
cesses under which these genes are inherited, the fluid as-
sociation and co-evolution of toxins and antitoxins and re-
veals the complexity of gene evolution in a bacterium with
high rates of horizontal gene transfer.
MATERIALS AND METHODS
Strains and phylogenetic analysis
Assemblies of 259 K. pneumoniae species complex strains
(Supplementary Table S1) were assembled using VEL-
VET (v1.2.07) (32) and annotated using PROKKA (v1.5)
(33,34). Prokka combines the use of five other tools to
identify features in the assemblies; Aragorn (v2.36) for tR-
NAs (35), Prodigal (v2.6) for coding sequences (CDSs) (36),
RNAmmer (v1.2) for rRNAs (37), Infernal (v1.1) for non-
coding RNA (38) and SignalP (v4.1) for signal leader pep-
tides (39). The core gene phylogeny was inferred from a core
gene alignment generated using Roary (40), and a maxi-
mum likelihood tree from the informative SNPs, chosen us-
ing SNP-sites (41) (v2.3.2), was constructed using RAxML
(v8.2.8) (42) with 100 bootstrap replicates.
Toxin–antitoxin prediction
SLING (v1.1), a tool to identify linked genes (43), was used
to search for toxins and their cognate antitoxins using the
built-in toxin domain database provided in SLING. Briefly,
SLING uses hidden markov models of known toxin do-
mains to search the genomes for putative toxins. Following
the toxin search, SLING will search for an adjacent CDS
for the cognate antitoxin based on a set of given structural
requirements. We applied the default structural parameters
for a TA search in the filtering step (minimum toxin length:
30 aa, maximum toxin length: 200 aa, minimum antitoxin
length: 50 aa, maximum antitoxin length: 150 aa, maximum
overlap between toxin and antitoxin: 20 bp, maximum dis-
tance between toxin and antitoxin: 50 bp, order: antitoxin
either upstream or downstream to toxin). SLING provides
an expected length for some of the toxin domains. In that
case, only CDSs which were no more than 100 aa longer or
shorter than the expected length were accepted. Following
the filtering, SLING uses pairwise protein sequence align-
ments to assign clusters to all toxins and antitoxins.
The local sequence identity and alignment coverage per
toxin and antitoxin group was taken from the BLAST+ re-
sults. All the antitoxin and toxin sequences from each group
were aligned using MUSCLE (v3.8.31) (44). The global
sequence identity was calculated as the pairwise sequence
identity between every two sequences in the multiple se-
quence alignment.
Statistical analysis
Statistical analyses were performed in R (v3.3.1). Briefly,
the toxin and antitoxin accumulation curves were gener-
ated using the specaccum function in the vegan (45) library
with 100 random permutations. Principal component anal-
ysis was performed using the prcomp function. Association
between toxins and lineage or the presence of antimicro-
bial resistance (AMR), virulence or plasmid replicons were
performed using Fisher’s exact test and corrected for mul-
tiple testing using the false discovery rate (FDR) with the
p.adjust function. Differences between groups (K. pneumo-
niae species complex, toxin categories) were assessed using
the Wilcoxon test and corrected using FDR.
Toxin group classification
Toxin groups which were found in over 80% of isolates
of all species were assigned as ‘ubiquitous’. Toxin groups
which had at least four copies and were found to be sig-
nificantly associated with K. pneumoniae complex species
(Fisher’s exact test, FDR corrected, P < 0.01) were as-
signed ‘species associated’. Toxin groups which were not
ubiquitous or species associated were assigned ‘sporadic’
if they had 26 copies or more or otherwise, if they were
found to be significantly associated with the presence of
AMR genes, virulence genes or plasmid replicons (Fisher’s
exact test, FDR corrected, P < 0.01). The remaining toxin
groups were assigned ‘rare’. Changing the sequence simi-
larity thresholds for grouping toxins increased the number
of toxin groups however the number of ubiquitous, species-
associated and sporadic toxin groups stay constant (Sup-
plementary Figure S1A). There is an increase in the num-
ber of rare toxin groups which is driven by an increase in
the number of singleton toxin sequences. The ubiquitous
toxin groups and species-associated toxin groups were ro-
bust and stable across all identity thresholds (Supplemen-
tary Figure S1B and C). Our chosen BLAST identity cut-
off of 75% allows separation of sequences which share simi-
lar domains, for instance, DNA binding domains, yet keeps
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homologous sequences together and does not separate se-
quences by species due to drift (Supplementary Figure S1D
and E).
Definition of novel versus known antitoxins
All in-silico predicted and experimentally validated type
II and IV antitoxin sequences were downloaded from
the TA database TADB (v2, downloaded on 27.08.17)
(46,47) and performed pairwise comparisons between all
antitoxin sequences identified by SLING using protein-
protein BLAST+ (v2.7) (48). A SLINGantitoxin groupwas
marked as ‘known’ if one or more of the antitoxins in that
group shared at least 75% identity and an E-value of 0.01
or lower with an antitoxin from TADB (consistent with our
definition of an antitoxin group). Interpro-scan (v5) was
used to assign function to the sequences of the novel anti-
toxins (49). Sequences whichwere predicted to be antitoxins
by Interpro-scan were also marked as ‘known’. Otherwise,
the group was marked as ‘novel’.
Orphan antitoxins
Antitoxin sequences from an antitoxin cluster were grouped
using cd-hit (v4.7) (50) with an identity threshold of 90%
and word size of five to remove redundant sequences. An
antitoxin protein database of the cd-hit representative anti-
toxins was constructed using BLAST+ (v2.7) (48). The six
frame-translated K. pneumoniae genomes from the SLING
output (43) were aligned against the antitoxin database us-
ing blastn. A CDS was considered an ‘orphan antitoxin’ if
(i) it was between 50 and 150 aa long, (ii) it shared 75%
sequence identity or more to an antitoxin in the collection
and (iii) the alignment was 50 aa or longer. These settings
were chosen to be consistent with our definition of iden-
tity between antitoxin sequences in our original analysis.
The sequences 1000 bp upstream and downstream to the
orphan antitoxins were clustered with the respective 1000
bp sequences surrounding the original antitoxin in the vi-
able TA pair using cd-hit-est with 80% identity threshold
and word size of five. If orphan antitoxin context sequences
were in the same cd-hit cluster as the sequences of the orig-
inal antitoxin, they were marked as ‘same’ and ‘different’
otherwise.
Identification of AMR genes, virulence genes and plasmid
replicons
A collection AMR genes were obtained from the mod-
ified version of ARG-ANNOT available on the SRST2
website (https://github.com/katholt/srst2/tree/master/data,
downloaded on 02.10.16) (51,52). A dataset of virulence
factors was obtained from the Klebsiella-specific BIGSDB
(http://bigsdb.pasteur.fr/klebsiella/klebsiella.html, down-
loaded on 22/02/16). The PlasmidFinder database (v1.3)
of plasmid replicons was downloaded using ARIBA (v2.12)
(53,54). Presence or absence of a gene in a genome was
determined using ARIBA (v2.12) with default settings (54).
Nucleotide–nucleotide BLAST+ (v2.7) of the VELVET
assemblies against the target gene databases was used to
identify contigs which contain a gene of interest (AMR,
virulence or plasmid) (48). A match was determined if any
of the associated genes had a BLAST bit score of 200 or
more.
Phenotypic testing
Bacterial strains, plasmids and oligonucleotides used in this
study are listed in Supplementary Table S2. The sequences
of synthesised genes, including mutated ribosomal binding
sites and restriction sites where appropriate, are listed in
Supplementary Tables S3 and 4.
Strains were cultured routinely on LB media. Where ap-
propriate, bacteria harbouring plasmids were cultured on
LB media supplemented with 100 g/ml ampicillin or 30
g/ml chloramphenicol.
Toxin and antitoxin sequences predicted from compu-
tational analysis were synthesised, cloned and sequence-
verified using the GeneArt DNA synthesis service (Ther-
moFisher Scientific, DE). Toxin sequences were cloned into
pNDM220 under Plac control (55), and antitoxin sequences
into pBAD33 under Para control (56) (Supplementary Ta-
bles S3 and 4). LB agar plates were supplemented with 1
mM of isopropyl -D-thiogalactopyranoside (IPTG) for
the induction of Plac and 0.2% w/v of L-arabinose for the
induction of ParaB. Overnight cultures were washed once
and then serially diluted (10−1 to 10−6) in sterile phosphate-
buffered saline (PBS). 10 l of the original and diluted cul-
tures (10−1 to 10−6) were spotted on LB agar plates contain-
ing the induction supplements.
Lyophilised plasmids were rehydrated in nuclease-free
water. In order to ensure that in vitro validation experi-
ments were performed using a single clone of each syn-
thesised construct, each plasmid was propagated and pre-
pared from a cloning strain of E. coli. Briefly, E. coli was
cultured aerobically in 100 ml LB broth to an OD600 of
∼0.5 (200 rpm, 37◦C). Cells were harvested by centrifuga-
tion and resuspended in ice-cold 10 mM calcium chloride
(CaCl2) solution. Cells werewashed three times inCaCl2 so-
lution, collected by centrifugation, resuspended in 10 mM
CaCl2 containing 25% v/v glycerol, and frozen at −80◦C.
One microlitre of each plasmid solution was used to trans-
form these chemically competentE. coli by heat shock (plas-
mid incubated with bacteria on ice for 30 min, heat shock
at 42◦C for 30 s, 5 min immediate recovery on ice). Trans-
formed cells were recovered for 1 h at 37◦C (200 rpm), and
transformants were selected for on solid LB media supple-
mentedwith appropriate antibiotics. One colonywas picked
and single-colony purified; the purified clone was then cul-
tured overnight in 5 ml LB supplemented with antibiotics.
Plasmids were extracted from 2 ml of each culture using
the QIAprep Spin Miniprep kit (Qiagen, #27104) and the
remaining culture was mixed with glycerol (25% v/v final
concentration) and stored at −80◦C.
RESULTS
Type II and type IV TA systems are highly abundant in the
K. pneumoniae species complex
A total of 259K. pneumoniae species complex genomes rep-
resenting the global diversity were included in this study
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(31) (Supplementary Table S1). These include 222 K. pneu-
moniae sensu stricto, 18 K. quasipneumoniae and 19 K. vari-
icola isolates (Figure 1A), including isolates taken from
community and hospital acquired infections, those caus-
ing invasive and non-invasive disease and those isolated
from both animals and plants (31). Although four addi-
tional species from this complex have been described (57–
59), our study focuses on these three species as there is a
well described dataset consisting of these species that re-
flects the clinically relevant diversity of the K. pneumoniae
species complex (31).
SLING was used to search for TA pairs within our
genomic dataset (43). SLING uses Pfam hidden Markov
model profiles of known toxins to search for candidate tox-
ins within a given genomic dataset using HMMER (60,61).
Where identified, SLING searches for cognate protein-
coding antitoxins in proximity to the identified toxin, fol-
lowing a set of predefined structural rules. We applied con-
servative requirements for a TA pairing to be considered a
valid TA system and discarded any putative toxins and anti-
toxins which deviated from our criteria (see ‘Materials and
Methods’ section). Finally, all candidate toxin and antitoxin
pairs are grouped according to sequence similarity using a
cut off of 75% local amino-acid sequence identity. For clar-
ity, a group of toxins or antitoxins which have been clustered
together based on their amino-acid sequence identity are re-
ferred to as ‘toxin group’ and ‘antitoxin group’, respectively.
The toxin groups are named by the profile by which they
were found.
Using a collection of 55 (52 type II, 3 type IV) Pfam toxin
profiles as our input for the search strategy (43), we identi-
fied a total of 140 toxin groups (130 type II, 10 type IV)
and 233 antitoxin groups (211 type II, 23 type IV), form-
ing 244 different TA structures in the genomes included
in this study (Supplementary Tables S5 and 6). Altogether,
TA systems were highly prevalent in all members of the K.
pneumoniae species complex, with a median of 19 loci per
isolate genome (range 11–29, Figure 1B). Principal com-
ponent analysis showed a clear separation into the three
species based on toxin repertoire (Figure 1C). Furthermore,
K. variicola has a higher median of 22 TA systems per iso-
late compared to 18 and 19 in the other two species (Fig-
ure 1D; pairwise Wilcoxon rank sum test P < 0.01, FDR
corrected).
Based on sequence similarity, the number of defined toxin
groups per toxin Pfam profile ranges from 1–13 (see Sup-
plementary Table S7). The mean sequence variation within
any one toxin group ranged from 68.95 to 100% local iden-
tity at the amino-acid level covering 59.33–100% of the full
length of the protein (46.37–100% amino-acid identity over
the complete protein) (Supplementary Table S5). This high-
lights the diversity of candidate toxins linked to function-
ally tested domains that were identified in this study. For in-
stance, we aligned the sequences of a toxin group 31H con-
taining the HicA domain to the toxins containing the HicA
domain taken from the existing TA database, TADB (46,47)
(Supplementary Figure S2). Whilst some key residues are
conserved throughout, there are considerable variations be-
tween the sequences taken fromTADB to each other as well
as to our predicted toxin.
Redefining toxins based on their distribution patterns
We classified the 140 identified toxin groups into four cate-
gories based on their distribution in our dataset (see ‘Mate-
rials andMethods’ section) (Figure 1E; Supplementary Fig-
ure S3 and Table S5). Seven toxin groups were ubiquitous
(one type IV), present in over 80% of the isolates included in
this study and from all three species. Fifteen toxin groups,
all type II toxins, differed in prevalence between the three
species (Fisher’s exact test P< 0.01, FDR corrected, Figure
1E). Twenty-three toxin groups (one type IV) (17%) were
distributed sporadically with no species association, includ-
ing a number which were associated with clinically relevant
genes. Finally, the remaining 95 toxin groups (eight type IV)
(68%) were rare and found in fewer than 10% of the isolates
(Supplementary Figure S3).
Within the ubiquitous toxin groups, we observed sig-
nificantly higher nucleotide identity for toxins within the
same species compared to toxins from other species (me-
dian 99.4% compared to 93.51%,Wilcoxon rank sum test,P
< 0.001, Supplementary Figure S4). The median nucleotide
identity for sporadic toxin groups for toxins within a species
was 97.06% compared to 96.57% between species. This elu-
cidates the evolution of the ubiquitous toxin groups due to
genetic drift within a specific member of the species com-
plex, compared to the likely mobile, sporadic toxin groups
where this effect is not observed.
The seven ubiquitous toxin groups are known to inhibit
translation via mechanisms that do not include RNA cleav-
age: toxin group 5H (polyketide cyc) is a homolog of the
RatA toxin in E. coli which inhibits translation by binding
to the 50S ribosomal subunit (62). Similarly, toxin group
34H (Fic) is a Doc toxin which inhibits translation by
phosphorylating and concomitantly inactivating elongation
factor TU (EF-Tu) (63). Toxin groups 22H and 8H with
the GNAT and DUF3749 domains are acetyltransferases
known to inhibit translation by acetylating aminoacyl-
tRNA (30,64). Group 27H contains a HipA domain which
is well described for its association with the high persister
phenotype (20,65) and inhibits translation by phosphory-
lating and concomitantly inactivating glutamyl-tRNA syn-
thetase (66). Toxin group 11H with the CptA domain be-
longs to type IV TA system which inhibits cytoskeleton as-
sembly (67). Finally, group 10H with the HD domain is a
phosphohydrolase which is a putative toxin domain from
TADB but its exact function is unknown (43,46–47).
The species associated toxin groups present different dis-
tribution patterns across the three Klebsiella species used
in this study. Klebsiella pneumoniae sensu stricto possesses
three toxin groups in lower prevalence compared to the
other two species (51H (HigB), 64H(Fic) and 25H (Gp49))
(Figure 1E). Klebsiella variicola possess five toxin groups
in higher prevalence compared to K. pneumoniae sensu
stricto and K. quasipneumoniae (42H (YdaT), 9H (Zeta),
2H (PemK), 33H (RelE) and 87H (HicA) domains). Toxin
group 87H (HicA) is specific to K. variicola and is not ob-
served in the other two species in our dataset. On the other
hand, toxin groups 16H (ParE) and 17H (RelE) domains
are less common inK. variicola.Finally,K. quasipneumoniae
lacks three toxin groups (21H (PIN), 26H (ParE) and 13H
(Gp49)), and rarely possesses toxin group 7H (Fic). On the
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Figure 1. Diversity of toxins inKlebsiella pneumoniae species complex. (A) Core gene phylogeny of the 259 selectedK. pneumoniae species complex genomes.
(B) Number of predicted TA systems per isolate. (C) First two principal components of PCAanalysis of toxin repertoire coloured byK. pneumoniae complex
species (yellow:K. pneumoniae sensu stricto, blue:Klebsiella quasipneumoniae, green:Klebsiella variicola). (D) Number of predicted TA systems per isolate,
stratified by K. pneumoniae complex species. Pairwise Wilcoxon rank sum test, *P < 0.01, **P < 0.001, FDR corrected. (E) Fraction of isolates from each
K. pneumoniae complex species possessing each of the toxin groups. Toxin groups are categorised by their distribution patterns (detailed in Supplementary
Table S5). The toxin Pfam profile used to identify the toxin group is in brackets.
other hand, toxin group 37H (BroN) is observed in higher
prevalence in K. quasipneumoniae relative to the other two
species. Of these K. quasipneumoniae isolates, 11% possess
three copies of this toxin group and 16% possess two copies
(Supplementary Figure S5).
Prediction of novel antitoxins
Accumulation curves of the unique toxin and antitoxin
groups identified using SLING suggest that sampling ad-
ditional K. pneumoniae species complex genomes will lead
to further identification of new candidate antitoxins (Fig-
ure 2A) (43). To assess whether the identified antitoxins
were known or novel, we compared their sequences to all
type II and type IV antitoxin sequences retrieved from the
TADB database (46,47) (see ‘Materials and Methods’ sec-
tion). 195 (173 type II, 22 type IV) of the 233 (211 type II, 23
type IV) antitoxins detected in our study were not found in
TADB and seen to be novel candidate antitoxins linked to a
known toxin (Supplementary Table S6). For completeness,
we assigned function to the 195 novel antitoxin groups us-
ing interpro-scan (Supplementary Table S6) (49). We iden-
tified 19 additional antitoxin groups which matched known
antitoxins by interpro-scan which were not in TADB (an-
titoxins of toxin profiles YdaT (8), CbtA (4), CcdB (2), Fic
(1), PemK (1), PIN (1), HigB (1) and HicA (1)), leading to
a final count of 176 novel antitoxins (76%).
About 72% of novel antitoxins (127/176) could not be as-
signed a putative function (Supplementary Table S6). Five
groups contain one of the toxin profiles used in the toxin
search and are the result of disrupted toxins. Twelve groups
were predicted to be DNA binding or transcriptional reg-
ulators which are plausible functions for antitoxins due
to the auto-regulation of the TA operon through condi-
tional cooperativity (22,68). Another 12 groups were as-
signed to be intrinsically disordered proteins (69). The re-
maining groups contain profiles indicating other functions,
such as domains of unknown function, ABC transporters,
prophages and other functional categories (Supplementary
Table S6).
For each of the toxin groups, we examined the arrange-
ment of the linked antitoxin: upstream of the toxin (denoted
AT-T) or downstream of it (denoted T-AT) (Figure 2B). Of
the known antitoxins, 72% were located upstream of the
toxin compared to 50% of the novel antitoxins (P = 0.007,
Chi squared test).
Looking at the association between specific toxins and
antitoxins we found that with a greater number and diver-
sity of defined toxin groups belonging to the Pfam profile
used to search for the toxins, there were concomitantlymore
antitoxin groups linked to those toxins (0.88 Pearson cor-
relation, Figure 2C). The exceptions include the YdaT do-
main which was found with 28 candidate antitoxin groups
and linked to only 9 toxin groups. This both suggests there is
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Figure 2. Identification of novel antitoxins in the Klebsiella pneumoniae genomes. (A) Accumulation curves of unique toxins and antitoxins groups found
in an increasing collection of K. pneumoniae genomes. (B) Count of antitoxin groups found only upstream (AT-T) and downstream (T-AT) relative to each
toxin Pfam profile, coloured by known or novel. (C) Number of toxin groups of each toxin Pfam profile, relative to the number of antitoxin groups found
in their proximity.
coevolution of TA pairs along with instances where a range
of different antitoxins can inhibit the same toxin.
Fluid association and distribution of toxin–antitoxin pairings
We found that a single toxin group can be found with up
to a maximum of 12 discrete antitoxins, highlighting the
‘mix and match’ nature of TA associations (70). It is im-
portant to note that the antitoxin groups are substantially
different from each other as we applied a cut off of 75% lo-
cal amino-acid sequence identity for two antitoxins to be in
the same group. Furthermore, the mean sequence variation
within any one antitoxin group ranged from 74.64–100% lo-
cal identity at the amino-acid level covering 61–100% of the
alignment length (59.88–100% aa identity over the complete
protein), highlighting further the diversity in the candidate
antitoxins identified (Supplementary Table S6).
In addition to a range of different antitoxins paired
to the same toxin, toxins also showed a range of operon
structures (Figure 3A); some toxin groups were linked
to a single antitoxin in a conserved position either up-
stream or downstream of the toxin. Other toxin groups were
found in multiple arrangements with the antitoxin sequence
and/or location of the antitoxin relative to the toxin chang-
ing (Figure 3B–H). For the ubiquitous toxin groups, only
three groups were found in a single arrangement (groups
11H (CptA, a type IV toxin), 5H (polyketide cyc) and 8H
(DUF3749)) (Figure 3B and Supplementary Figure S6).
Three other toxin groups (groups 22H (GNAT), 34H(Fic)
and 27H(HipA)) were observed in two or three structures
often with one structure dominating (>90% of isolates) and
the others being rare occurrences of the other structures
(<3% of isolates, Figure 3C andD). Although theHD toxin
group is ubiquitous, one TA arrangement, found in 80% of
isolates, is specific for K. pneumoniae sensu stricto, missing
inK. variicola and replaced by a structure specific toK. vari-
icola (Figure 3D and Supplementary Figure S6).
The species-associated toxin group 7H (Fic), is found in
one arrangement which is specific to K. variicola (Figure
3E). Toxin group 51H (HigB) is associated with two unique
antitoxins with one being specific to K. quasipneumoniae
(Figure 3F). Alternatively, other toxin groups possess mul-
tiple operon structures with no clear species association, for
instance, toxin group 42H (YdaT) is observedwith seven an-
titoxin groups in eight different arrangements (Figure 3G
and Supplementary Figure S7). Other than in a single case
(18H (CcdB)), the sporadically distributed toxins were not
seen in species-specific arrangements emphasising they are
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Figure 3. Diversity in the observed operon structures for the different toxin categories. (A) Examples of range of antitoxins and possible operon structures
for a toxin (a) toxin group found in a single structure with a single antitoxin group (b) toxin group found in two different structures with two different
antitoxin groups (c) toxin group found in five different structures with four different antitoxin groups. (B–H) Fraction of isolates from each Klebsiella
pneumoniae species complex possessing each of the operon structures of seven example toxin groups: (B–D) ubiquitous, (E and F) species associated, (H)
sporadically distributed.
unlikely to be vertically inherited (Figure 3H and Supple-
mentary Figure S8)
Most of the antitoxins we identified were toxin group spe-
cific. However, antitoxin from group 52P was found both
with toxin group 31H (HicA) in seven isolates and with
toxin group 54H (BroN) in a single isolate. Interestingly, it
was always found upstream to the 31H (HicA) toxin and
downstream 54H (BroN) toxin. The antitoxin proximate to
31H (HicA) shares 83.2% amino acid sequence identity with
the antitoxin proximate to 54H (BroN) antitoxin. This anti-
toxin is not found in TADB but encodes for a domain of un-
known function DUF1902 (PF08972) which is in the same
Pfam clan as many other antitoxins (Met repress, CL0057).
Phenotypic testing in silico predictions of toxins and confir-
mation of novel antitoxins
Due to the apparent diversity of TA systems within and
between species and the novel combinations of toxin and
antitoxins found in this study, we tested the ability of 17
candidate toxins, representing the diversity of toxins within
a given group and from a range of genomic backgrounds,
to inhibit bacterial growth in our E. coli model system
(see ‘Materials and Methods’ section). Selected were: four
ubiquitous, four species associated, seven sporadically dis-
tributed and two rare candidate toxins (Supplementary Ta-
ble S3 and Figure S9).
We confirmed the toxicity of all the species associated
toxins that we tested (groups 51H (HigB), 7H (Fic), 87H
(HicA) and 37H (BroN)). Of the remaining toxins we were
able to observe toxicity from the 27H (HipA) toxin group
which is ubiquitous across the species complex as well as
four of the seven sporadically distributed toxins tested from
groups 14H (Gp49), 24H (Gp49), 61H (CcdB), 44H (ParE)
and a rare toxin from the 31H (HicA) group. The ubiqui-
tous type IV toxin we tested, 11H ((CptA)), could not be
successfully synthesised or cloned, likely due to its toxic ac-
tivity. The rest of the toxins tested showed no toxic activ-
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ity under the conditions tested in our assay (summarised in
Supplementary Table S3).
Subsequently, we tested 14 candidate antitoxins for their
ability to counteract the toxicity of their cognate toxin in
our E. coli model system (including 10 novel antitoxins;
this study; Figure 4 and Supplementary Table S4). Eight
of the fourteen antitoxins (57%) led to complete inhibi-
tion of the toxic activity, five of which were novel antitox-
ins (summarised in Supplementary Table S4). Three of the
confirmed novel antitoxins were predicted to contain DNA
binding domains by interpro-scan (39P, 27P, 147P). One an-
titoxin contains a domain of unknown function (52P) and
the final antitoxin did not match any existing entry in In-
terpro (44P). Three of the confirmed antitoxins in the T-
AT format were located downstream of the toxin (groups
27P (Gp49), 147P (HigB) and 39P (HigB)). An additional
known antitoxin only partially inhibited toxicity (67P).
For completeness, for operons that had the structure
AT1-T-AT2, we tested both AT1 and AT2. In both cases,
AT1 only was confirmed to inhibit the toxin’s activity whilst
we did not observe toxin inhibition activity with AT2.
Finally, these data also revealed some more unexpected
findings. In two cases the predicted antitoxins were them-
selves found to be toxic in our experimental system (45P,
62P) (Figure 4). One of these antitoxins is a well-described
antitoxin with a HicB domain (62P). In addition, we con-
firmed both versions of antitoxin group 52P, associatedwith
toxins from markedly different groups (31H (HicA) and
54H (BroN)), were able to counter toxin group 31H (Figure
4; Supplementary Table S4 and Figure S9). Although the
antitoxin group is linked to two different toxins and the two
versions of the antitoxin share only 83.2% amino acid iden-
tity, both versions inhibit the activity of this toxin. We were
unable to confirm the toxicity of toxin group 54H (BroN)
(Supplementary Table S3 and Figure S9), thus we could not
confirm inhibition of this toxin group. Finally, we tested two
variants of the toxin group 51H (HigB); a shorter protein
(53 aa) which was observed with antitoxin group 39P and a
longer protein (103aa) observed with antitoxin group 147P.
The C-terminus of the longer toxins is 83% identical to the
shorter protein. The two antitoxins share 71% amino-acid
identity. We were only able to confirm the toxicity of the
shorter 51H toxin. Nonetheless, we tested both antitoxins
39P and 147P with the shorter 51H toxin, and found that
both antitoxins are functional and able to inhibit the toxin.
Orphan antitoxins are abundant in the population
We sought to determine whether the antitoxins in the TA
pairs were also present on the K. pneumoniae species com-
plex genomes as orphan genes uncoupled to a candidate
toxin gene. We aligned the predicted antitoxin sequences
against all the genomes and found a total of 2253 occur-
rences of orphan antitoxins belonging to 105 of the 233 an-
titoxin groups defined in this study (96 type II and 9 type IV)
(Figure 5A and Supplementary Table S8). Of these, 25% are
known antitoxins found in TADB or Interpro (26/105). For
80% (77/96) of type II and 89% (8/9) of type IV antitoxin
groups, we found fewer than 26 orphan copies in the entire
genome collection, i.e. occurrences of unpaired antitoxins
were rare and were found in fewer than 10% of genomes
(Figure 5A). Conversely two antitoxin groups, containing
the type II Fic and HipA toxin domains, were found un-
paired in more than 80% of the genomes (>207 copies)
across the species complex. In 35 of the 105 orphan anti-
toxin groups, we detected orphans in a species different to
that of the valid TA pair (Supplementary Table S8). For in-
stance, antitoxin group 89P of the HipA toxin was origi-
nally identified inK. quasipneumoniae. However, orphan an-
titoxins were found only in K. variicola (Figure 5A). Simi-
larly, antitoxin group 115P belonging to a PemK-containing
toxin was originally identified in K. variicola, but orphan
antitoxins were found in K. quasipneumoniae as well. Al-
together we did not observe significant differences in the
number of orphan antitoxins per strain between the three
species, with a median of nine orphans per strain across the
three species (Figure 5B) (pairwise Wilcoxon rank sum test,
FDR corrected, P > 0.05).
To assess the origin of orphan antitoxins we aligned the
upstream and downstream sequence surrounding the anti-
toxin with those found in valid TA pairs (Figure 5C) (see
‘Materials andMethods’ section). About 39%of the orphan
antitoxins (879/2253) share the same toxin-context as the
valid TA pair. Of these, 92% also share the same non-toxin-
context, indicating that they are in the same genetic con-
text as the valid TA pairs from the same group (Figure 5D).
65% of orphans which did not share the toxin-context of the
original TA pair (893/1374) do share the non-toxin context.
In 20% of cases (470/2253) neither the toxin-context or the
non-toxin-context match the valid TA pair, i.e. the orphan
antitoxins were surrounded up- and downstream by unre-
lated sequences to any of our detected TA pairs.
To confirm whether these were truly orphan antitoxins,
we searched for a CDS within the toxin-context that could
function as the toxin. In 49% of orphans (1,107/2253) we
found a CDS within the context region that does not con-
tain a known toxin domain and could be a candidate for a
novel toxin (Figure 5E). In 43% of cases (947/2253) a toxin
containing the original Pfam profile used in the search was
found but the CDS was discarded due to the conservative
structural requirements we applied for a TA system (Figure
5E). Thesemay be false negatives in our original analysis, or
otherwise TAs which have diverged from the expected struc-
ture for a functional TA pair. In 8% of cases (171/2253) the
predicted antitoxin was truly orphan as we could not find
a CDS longer than 50 aa in the context region that could
function as a toxin. In 1% of cases (28/2253), the orphan
antitoxin was close to the contig edge or proximate to a re-
gion with more than eight unknown nucleotides (N/X) and
therefore we could not confirm the presence or absence of a
toxin in its proximity.
The association between toxins and antimicrobial resistance
genes, virulence genes or plasmid replicons
Considering the breadth of genomes included in this study
we looked for physical linkage or co-occurrence between
identified TA system genes and marker genes associated
with horizontal gene transfer, AMR or virulence. Several
of the sporadically distributed toxin groups were associ-
ated with clinically relevant AMR or virulence genes as
well as plasmid replicons linked to the spread of AMR in
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Toxin Tested known antitoxin Tested novel antitoxin Untested partner antitoxin
Figure 4. Phenotypic testing predicted TA combinations. Toxins in circles, tested novel antitoxins in green and tested known antitoxins in grey. For operon
structures AT1-T-AT2, the untested partner antitoxin is in a dashed square. LB agar plates were supplemented with 1 mM IPTG for the induction of toxin
Plac promoters and 0.2% w/v of L-arabinose for the induction of antitoxin Para promoters. Overnight cultures were serially diluted (10−1 to 10−6) in
PBS. Figures were cropped from the original images for clarity. Original images available at: https://github.com/ghoresh11/kpneumoniae TAs/tree/master/
results/Functional validation orig.
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Figure 5. Orphan antitoxins in Klebsiella pneumoniae genomes. (A) Number of orphan antitoxins identified from each antitoxin group, coloured by K.
pneumoniae complex species. The toxin Pfam profile of the toxin of the valid TA pair is in brackets. (B) Orphan antitoxins per strain stratified by K.
pneumoniae complex species. (C) Illustration of context analysis applied to each orphan antitoxin. The flanking sequences around each orphan antitoxin
were compared to the flanking sequences of the valid TA pair. Each flank was classified according to whether or not it matched the sequence of the original
TA pair. (D) Number of occurrences of orphan antitoxins classified by the similarity of their contexts’ to the valid TA pairs’. (E) Presence of a CDS in the
orphan antitoxin’s toxin-context.
Klebsiella and E. coli (Figure 6A and B, Fisher’s exact test
P < 0.01, FDR corrected). These included 24H (Gp49)
and 72H (HD) toxin groups which were significantly as-
sociated with multiple AMR genes, including those con-
ferring resistance to aminoglycoside, amphenicol, sulfon-
amide, tetracycline and beta-lactams, with 13–29% of toxin
genes found on the same contig as the respective AMR
genes (Figure 6C). 100% and 30% of toxins CDSs of toxin
groups 24H and 72H, respectively, were on the same con-
tig with an IncA/C plasmid replicon (Figure 6D). These
contigs shared 99% (24H) and 97% (72H) sequence identity
with the K. pneumoniae IncA/C-LS6 plasmid (JX442976),
originally isolated from carbapenem-resistant K. pneumo-
niae (71), as well as AMR plasmids pNDM-KN (24H),
pRMH760, pIMP-PH114 and pR55 (72H) (Supplemen-
tary Table S9) (72–75). Two toxin groups with a RES do-
main, 3H and 12H, were associated with multiple virulence
genes (Figure 6B, Fisher’s exact test P < 0.01, FDR cor-
rected) and one of these groups (3H) with the presence of
an IncHI1B plasmid replicon. Contigs containing these two
toxins showed over 99% sequence identity to K. pneumo-
niae virulence plasmids pK2044 and pLVPK (Supplemen-
tary Table S9) (76,77). Five other toxin groups which were
associated with AMR or virulence genes were also associ-
ated with the presence of plasmid replicons (Fisher’s exact
test P < 0.01, FDR corrected) (see Figures 6A–C).
DISCUSSION
We present a systematic in-depth analysis of the diversity
and evolution of TA systems in a large collection of a clin-
ically important member of the Enterobacteriaceae, the K.
pneumoniae species complex. We show that TA systems are
highly prevalent in the species complex, however, the under-
lying processes of the evolution of TA systems are likely to
be context-dependent. The toxins of these TA systems can
be classified based on their distribution patterns as ubiqui-
tous, species associated, sporadically distributed (often with
associations to clinically important genes) or rare. The evo-
lution of ubiquitous toxins is likely vertically inherited, as
we observe higher nucleotide identity between toxins of the
same species than between species. We do not observe the
same effect for the sporadic toxins, suggesting that some
TA systems are more mobile than others. Importantly, the
classification presented in this study is based on the dataset
used, which was aimed to capture the diversity of the K.
pneumoniae species complex. It is possible that further sam-
pling of under-represented lineages would increase power
and refine the classification.
The pairing of antitoxin to toxin is not fixed; for each
toxin we found a range of candidate antitoxins in differ-
ent arrangements, putatively able to inhibit the same toxin.
Sampling of more genomes lead to a large diversity in an-
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Figure 6. Toxin groups associated with AMR genes, virulence genes and plasmid replicons. Number of unique AMR (A) and virulence (B) genes associated
with each of the toxin groups. Circles above bars indicate the toxin group is also associated with the presence of a plasmid replicon. Number of occurrences
of toxins in the genome collection, for the toxin groups associated with AMR genes (C), plasmid replicons (D) and virulence genes (E). An occurrence of
a toxin is coloured in dark if it is found on the same contig with one or more of the associated genes, light otherwise.
titoxins relative to toxins, suggesting the potential number
of interactions between toxins and antitoxins is large. No-
tably, some toxins are more stably coupled to a single an-
titoxin and observed in a single arrangement, whilst other
toxins were observed with a wide range of antitoxins and
operon arrangements. This highlights that the co-evolution
between toxin and antitoxin is dependent on the system and
context. This has functional implications as the antitoxin
and its interaction with the toxin can affect the functioning
of the TA system (78). Some antitoxins play a role in the reg-
ulation of the TAmodule as the TA pair regulate the expres-
sion of the TA operon (22,68). Furthermore, the interaction
of the toxin with the antitoxin will determine the specificity
of the inhibition and therefore would affect the dynamics
of both activation and deactivation of the TA operon. Fi-
nally, antitoxin instability is often the result of degradation
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/48/8/4357/5814049 by Faculty of Life Sciences Library user on 23 June 2020
4368 Nucleic Acids Research, 2020, Vol. 48, No. 8
by proteases (22), therefore the inhibition of an antitoxin in
response to stress can depend on the antitoxin sequence as it
would determine the specificity of interaction with proteins
that lead to its degradation (79). Future studies should be
held to explore the biological implications of pairing differ-
ent antitoxin groups with the same toxin group.
Even more, we often observe toxin or antitoxin groups
which are specific to a species, i.e. a TA pairing is observed
only in one particular genetic background. This suggests it
may be beneficial to possess a specific TA pair under one
genetic background compared to another. These results set
the ground for future studies understanding the biological
significance and expression of TA systems which are differ-
entially distributed under different genetic backgrounds.
Altogether 76% of the identified candidate antitoxins we
foundwere novel and not in the existing TAdatabase TADB
or Interpro (46–47,80). Furthermore, there is additional se-
quence diversity within each antitoxin group that we found.
These results emphasise the potential large diversity of anti-
toxins that could inhibit these toxins and our lack of knowl-
edge of the complete range and diversity of these systems.
Using an E. coli model system, we were able to confirm
the toxicity of 10 of 17 tested toxins (∼59%) and the in-
hibitory activity of 10 of 14 tested antitoxins (∼71%). Nine
of the tested antitoxins are novel and we were able to con-
firm the inhibition of five of them. We also found candidate
antitoxins downstream of the toxin, and confirmed the in-
hibitory activity of three of them, highlighting exceptions
to the common setup in which the antitoxin is encoded up-
stream of the toxin. These results could form the basis of fu-
ture studies investigating how different autoregulatory prin-
ciples enabled by upstream or downstream antitoxins might
affect the biology of a TA system. Whilst some of these
candidate antitoxins could be false predictions, the observa-
tion of known or confirmed antitoxins both upstream and
downstream to toxins suggests we cannot rule out any anti-
toxin candidate. Importantly, a negative result in our assays
does not rule out toxic or inhibitory activity of these pro-
teins, but rather could be the result of confounding effects in
our assays for example biological differences betweenE. coli
K-12 and K. pneumoniae, lack of protein expression or in-
correct folding in the heterologous host. Furthermore, our
assays do not indicate whether these systems are expressed
in the host bacterium or whether they have a physiological
role in the host cell.
There is an abundance of orphan antitoxins present in the
population which are unpaired to a functional toxin. These
include a number of the antitoxins we expressed and were
able to confirm their inhibitory activity (92 orphan copies
of 39P, 17 orphan copies of 24P and 45 orphan copies of
45P, Figure 4, Supplementary Table S7). Sources of orphan
antitoxins may be degrading TA pairs that are in different
genetic locations, older degraded TA systems or otherwise,
these could be candidates for new toxins which share the
same antitoxin as we have identified. Alternatively, some or-
phan antitoxins may be paired to a known toxin but were
discarded in our analysis due to the conservative structural
criteria we defined for a TA system, suggesting that the
prevalence of TA system in the K. pneumoniae species com-
plex presented here may be underestimated.
These orphan antitoxins may be serving a new purpose.
For example, theymay serve as anti-addictionmodules, pre-
venting the fixation of plasmids or other mobile genetic ele-
ments (81). Theymay be interactingwith the toxins of active
TA pairs and affecting their function. Alternatively, they
could also be conserved as remnants of a degraded TA locus
that have acquired functions in transcriptional regulation of
other genes in the genome (82).
The importance of this type of analysis is not limited to
TA systems, and presents general trends to distinguish be-
tween groups of genes of other gene systems. Pan-genome
analysis of bacterial datasets is often focused on the descrip-
tion of core compared to accessory genes without focussing
on the precise details within these two categories. Here we
showed that a more refined description of genes based on
their distribution across the K. pneumoniae population and
in the context of linkage to other genes. This finer grained
analysis can be applied in other settings and lead to novel,
highly relevant insights on evolutionary dynamics of poorly
understood genetic elements.
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